The Sabril REMS specifies elements, such as restricted product distribution, required vision testing, and mandatory risk-benefit assessments, to manage the risk of vision loss associated with Sabril.

• 喜保宁REMS强调了一些要素，诸如限制药品分销，必要的视力检查，以及强制性风险获益评估，以便控制喜保宁关联的视力丧失风险。